Abstract
This study presents the development of a kit formulation for the preparation of 99mTc-DMP-HSA, followed by a comparison of such kit-prepared 99mTc-DMP-HSA to 99mTc-RBCs in a volunteer. Reconstitution of the labeling kits with up to 5.55 GBq 99mTc afforded 99mTc-DMP-HSA preparations with a > 95% radiochemical purity for up to 8 h. Only minor differences were observed in the global distribution of both tracer agents, whereas the calculated ejection fractions were almost identical. The effective dose equivalent of 99mTc-DMP-HSA is 8.68 microSv/MBq.
MeSH terms
-
Humans
-
Male
-
Organotechnetium Compounds* / chemistry
-
Organotechnetium Compounds* / pharmacokinetics
-
Quality Control
-
Radiation Dosage
-
Radionuclide Ventriculography*
-
Reagent Kits, Diagnostic
-
Sulfhydryl Compounds* / chemistry
-
Sulfhydryl Compounds* / pharmacokinetics
-
Technetium Tc 99m Aggregated Albumin* / chemistry
-
Technetium Tc 99m Aggregated Albumin* / pharmacokinetics
Substances
-
Organotechnetium Compounds
-
Reagent Kits, Diagnostic
-
Sulfhydryl Compounds
-
Technetium Tc 99m Aggregated Albumin
-
technetium Tc 99m 2,3-dimercaptopropionic acid